Bilgic, A.; Kodjikian, L.; March de Ribot, F.; Vasavada, V.; Gonzalez-Cortes, J.H.; Abukashabah, A.; Sudhalkar, A.; Mathis, T.
Real-World Experience with Brolucizumab in Wet Age-Related Macular Degeneration: The REBA Study. J. Clin. Med. 2021, 10, 2758.
https://doi.org/10.3390/jcm10132758
AMA Style
Bilgic A, Kodjikian L, March de Ribot F, Vasavada V, Gonzalez-Cortes JH, Abukashabah A, Sudhalkar A, Mathis T.
Real-World Experience with Brolucizumab in Wet Age-Related Macular Degeneration: The REBA Study. Journal of Clinical Medicine. 2021; 10(13):2758.
https://doi.org/10.3390/jcm10132758
Chicago/Turabian Style
Bilgic, Alper, Laurent Kodjikian, Francesc March de Ribot, Vaishali Vasavada, Jesus H. Gonzalez-Cortes, Amro Abukashabah, Aditya Sudhalkar, and Thibaud Mathis.
2021. "Real-World Experience with Brolucizumab in Wet Age-Related Macular Degeneration: The REBA Study" Journal of Clinical Medicine 10, no. 13: 2758.
https://doi.org/10.3390/jcm10132758
APA Style
Bilgic, A., Kodjikian, L., March de Ribot, F., Vasavada, V., Gonzalez-Cortes, J. H., Abukashabah, A., Sudhalkar, A., & Mathis, T.
(2021). Real-World Experience with Brolucizumab in Wet Age-Related Macular Degeneration: The REBA Study. Journal of Clinical Medicine, 10(13), 2758.
https://doi.org/10.3390/jcm10132758